This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS July 26, 2011
ASCLS eNewsBytes
July 26, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Changes in E. coli testing pose surveillance challenges
Center for Infectious Disease Research and Policy    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The big Escherichia coli epidemic in Germany comes at a time when methods of testing for pathogenic E. coli are changing, posing some challenges for public health officials intent on detecting E. coli outbreaks quickly and monitoring trends as accurately as possible. Clinical laboratories are increasingly using enzyme immunoassay tests to detect Shiga toxin–producing E. coli, either along with or instead of the traditional method of growing the bacterium in a culture. More

Genetics advance at LSU Health Sciences Center
WVUE-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
DNA testing is rapidly becoming standard in day-to-day life for everything from criminal cases to medical treatment. Gregor Mendel, a man many consider the father of genetics, recently celebrated his 189th birthday. The offspring of his work is flourishing at the Louisiana State University Health Sciences Center. More

STA Coag ConneXion

STA Coag ConneXion is an easy to use, Windows 7 based user interface that offers comprehensive QC management, remote QC capability and standardized result reporting with the use of expert rules for auto validation. For more information on STA Coag ConnneXion, visit

Genetic testing for breast cancer risk
EmpowHER    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Most women know about mammograms for early detection of breast cancer. The BRCA1 and BRCA2 genetic tests are much less widely known. Dr. Douglas E. Levy and colleagues, provided a report on the guidelines for genetic testing. More

Mercy lab testing elevates hand sanitizer's use
Joplin Independent    Share    Share on FacebookTwitterShare on LinkedinE-mail
Recent data detailed the results of laboratory trials testing the killing power of a novel skin and wound cleanser/topical antiseptic against pathogenic bacteria and fungi cultured from patients cared for at St John's Hospital. It originally was designed to serve as a skin and hand sanitizer that provided broad spectrum coverage even against contamination that occurred hours after it was used. More

Boston health team battles Haiti cholera
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At a hospital in central Haiti, a team from Massachusetts General Hospital is among those helping to fight a cholera outbreak that has rebounded since it first struck the country last October. Five nurses and one doctor arrived to work 10-hour days at the hospital, caring for cholera-stricken residents who arrive in droves. Some in need of treatment have walked to the hospital or traveled on horseback; others are so sick they have been carried in. More

Specialists in Bone, Growth, Cartilage, Hypertension & Automation

IDS manufactures and markets specialist Immunoassays for diagnostic and research laboratory testing. These include fully automated and manual assays.

$9.8 million awarded for stem cell research
NBC Connecticut    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Connecticut Gov. Dannel Malloy announced that $9.8 million would be awarded to 20 Connecticut projects for stem cell research. The State of Connecticut Stem Cell Research Advisory Committee awarded the recipients at a grant review meeting in Farmington, Conn. More

How cancer stem cells fuel ovarian cancer
Zee News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study has found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow. Cancer stem cells are the small number of cells in a tumor that drive its growth and spread. Traditional cancer treatments do not kill these cells, which is why cancer treatments often fail. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.

World Health Organization says stop using blood tests for TB
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Using blood tests to diagnose active tuberculosis often leads to misdiagnosis, say the World Health Organization, who urge all countries to stop using the tests and rely instead on accurate microbiological or molecular tests. This is the first time the global health agency has issued a "negative" policy recommendation relating to TB, something they say "underscores the organization's determination" to advise governments when there is strong evidence that widespread practice is doing more harm than good. More

At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or

Avoiding ticks, mosquitoes and other summer health hazards
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Summer means more time outdoors — walking in the woods, gardening, picnicking. And that brings increased exposure to ticks, mosquitoes and some infectious diseases. But there are plenty of steps you can take to protect yourself. USA Today's Mary Brophy Marcus and Jonathan Shorman talk to public health experts. More

Innovative Tumor Marker/Vitamin D Products

Visit Fujirebio Diagnostics, Inc. at booth #14 during the AMT/CASMET Meeting in Miami and learn more about HE4 and CYFRA 21-1™ EIA assays in addition to Tumor Marker and Vitamin D Controls! MORE
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Colby Horton, Vice President of Publishing

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • July 19, 2011
  • July 12, 2011
  • July 5, 2011
  • June 28, 2011
  • June 21, 2011
  •  RSS Feed
    Most popular articles